Glenmark Pharmaceuticals launches MINYM gel for acne treatment
Glenmark Pharmaceuticals has launched a topical Minocycline 4% Gel under the brand name MINYM in India for the treatment of moderate to severe acne. According ... Read More
Glenmark Pharmaceuticals receives FDA Form 483 with 17 observations for North Carolina facility
Glenmark Pharmaceuticals, a global pharmaceutical company based in India, announced that it has been issued Form 483 with 17 observations by the United States Food ... Read More
Glenmark gets FDA nod for generic of psoriasis medication Enstilar Foam
Glenmark Pharmaceuticals has secured tentative approval from the US Food and Drug Administration (FDA) for Calcipotriene and Betamethasone Dipropionate Foam, 0.005%|0.064%. The product is the ... Read More
Glenmark Pharmaceuticals launches Covid-19 treatment FabiSpray in India
Glenmark Pharmaceuticals and Canadian pharma company SaNOtize Research & Development Corp. have launched the latter's Nitric Oxide Nasal Spray under the brand name FabiSpray in ... Read More
Glenmark Pharmaceuticals bags FDA approval for Metronidazole Vaginal Gel
Glenmark Pharmaceuticals said that it has bagged final approval from the US States Food and Drug Administration (FDA) for Metronidazole Vaginal Gel, 0.75%, which is ... Read More
Glenmark Pharmaceuticals gets FDA approval for Lexiscan Injection generic
Glenmark Pharmaceuticals said that it has secured tentative approval from the US Food & Drug Administration (FDA) for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) ... Read More
Glenmark gets marketing approval for Ryaltris in 13 European countries
Glenmark Pharmaceuticals said that it has secured marketing approval for Ryaltris, a fixed-dose combination nasal spray, in 13 countries across the European Union (EU) and ... Read More
Glenmark Pharmaceuticals gets FDA approval for Clindamycin Phosphate Foam
Glenmark Pharmaceuticals, an Indian pharma company, said that it has secured final approval for Clindamycin Phosphate Foam, 1% from the US Food and Drug Administration ... Read More
Glenmark Pharmaceuticals gets FDA approval for Nintedanib Capsules
Glenmark Pharmaceuticals Ltd said that it has secured tentative approval from the US Food and Drug Administration (FDA) for Nintedanib Capsules, 100mg, and 150mg. Nintedanib ... Read More
Glenmark Pharmaceutical launches Tiogiva in UK for COPD treatment
Glenmark Pharmaceutical has announced the UK launch of Tiogiva, a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI), for the treatment of chronic obstructive ... Read More